Bolt Biotherapeutics (BOLT) Return on Sales (2020 - 2025)
Historic Return on Sales for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to 3.33%.
- Bolt Biotherapeutics' Return on Sales rose 99700.0% to 3.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.25%, marking a year-over-year decrease of 11100.0%. This contributed to the annual value of 8.82% for FY2024, which is 300.0% down from last year.
- Per Bolt Biotherapeutics' latest filing, its Return on Sales stood at 3.33% for Q3 2025, which was up 99700.0% from 4.77% recorded in Q2 2025.
- In the past 5 years, Bolt Biotherapeutics' Return on Sales ranged from a high of 2.94% in Q1 2024 and a low of 602.24% during Q1 2021
- Over the past 5 years, Bolt Biotherapeutics' median Return on Sales value was 11.45% (recorded in 2023), while the average stood at 47.36%.
- As far as peak fluctuations go, Bolt Biotherapeutics' Return on Sales crashed by -5496000bps in 2021, and later surged by 5731100bps in 2022.
- Quarter analysis of 5 years shows Bolt Biotherapeutics' Return on Sales stood at 53.46% in 2021, then soared by 73bps to 14.17% in 2022, then skyrocketed by 40bps to 8.57% in 2023, then fell by -3bps to 8.82% in 2024, then skyrocketed by 62bps to 3.33% in 2025.
- Its last three reported values are 3.33% in Q3 2025, 4.77% for Q2 2025, and 9.05% during Q1 2025.